MatchTx
Curated by SignalDeep Genetic Signatures to match therapeutics to cancer patients
Overview
MatchTx is a Big Data healthcare analytics software company that has licensed its technology from The Ohio State University. The product matches patients to cancer drugs and clinical trials with novel methods to find best matches using genetic, clinical, and outcome data. It uses Deep Genetic Signatures to predict how well the patient will respond to a drug, or which treatment is best, based on characteristics and outcomes of the best-matched cohorts. It uses early trials data and outcomes to screen out patients predicted to have poor outcomes in clinical trials, and adapt trials dynamically to get drugs to market faster. The company was awarded a competitive $125k grant from the Third Frontier Program of the State of Ohio.
Key facts
- Founded
- 2015
- Headquarters
- Columbus, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Sign up to view